Kissei Pharmaceutical Co., Ltd. (TYO:4547)

Kissei Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	29,685	29,057	25,169	22,894	25,893	30,013
Short-Term Investments	24,008	25,367	23,485	23,039	23,706	23,139
Cash & Short-Term Investments	53,693	54,424	48,654	45,933	49,599	53,152
Cash Growth	-12.97%	11.86%	5.92%	-7.39%	-6.69%	19.57%
Receivables	29,531	30,761	28,951	27,790	22,083	21,956
Inventory	23,877	25,521	24,979	26,296	22,798	18,987
Other Current Assets	3,847	4,263	4,396	4,532	6,161	5,247
Total Current Assets	110,948	114,969	106,980	104,551	100,641	99,342
Property, Plant & Equipment	28,823	28,093	27,069	24,861	24,579	24,074
Long-Term Investments	100,555	129,513	107,544	128,910	94,034	112,574
Goodwill	-	176	242	309	-	-
Other Intangible Assets	1,966	1,793	1,652	1,683	1,507	1,569
Long-Term Deferred Tax Assets	403	538	566	608	433	524
Other Long-Term Assets	24,157	-	1	2	1	1
Total Assets	266,852	275,086	244,059	260,929	221,200	238,087

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	5,293	6,661	4,602	4,893	4,617	4,104
Accrued Expenses	2,031	2,298	2,192	1,856	1,679	1,721
Short-Term Debt	1,250	1,250	1,280	1,340	1,490	1,640
Current Income Taxes Payable	2,060	5,006	1,474	2,380	408	3,497
Other Current Liabilities	5,964	6,473	7,030	7,194	6,763	7,782
Total Current Liabilities	18,064	21,688	16,578	17,663	14,957	18,744
Pension & Post-Retirement Benefits	206	220	202	209	192	181
Long-Term Deferred Tax Liabilities	18,432	21,029	16,481	21,188	10,426	16,259
Other Long-Term Liabilities	588	614	673	735	812	724
Total Liabilities	37,290	43,551	33,934	39,795	26,387	35,908

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	24,356	24,356	24,356	24,356	24,356	24,356
Additional Paid-In Capital	25,043	24,243	24,226	24,226	24,226	24,226
Retained Earnings	137,299	136,253	131,488	127,310	125,576	118,183
Treasury Stock	-14,815	-15,513	-14,520	-13,209	-12,912	-12,912
Comprehensive Income & Other	56,220	60,806	43,453	57,344	32,653	47,532
Total Common Equity	228,103	230,145	209,003	220,027	193,899	201,385
Minority Interest	1,459	1,390	1,122	1,107	914	794
Shareholders' Equity	229,562	231,535	210,125	221,134	194,813	202,179
Total Liabilities & Equity	266,852	275,086	244,059	260,929	221,200	238,087

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,250	1,250	1,280	1,340	1,490	1,640
Net Cash (Debt)	52,443	53,174	47,374	44,593	48,109	51,512
Net Cash Growth	-13.21%	12.24%	6.24%	-7.31%	-6.61%	20.61%
Net Cash Per Share	1263.37	1279.38	1086.01	985.30	1043.24	1117.03
Filing Date Shares Outstanding	41.74	41.45	41.44	44.21	45.96	46.12
Total Common Shares Outstanding	41.74	41.45	42.81	44.21	46.12	46.12
Working Capital	92,884	93,281	90,402	86,888	85,684	80,598
Book Value Per Share	5465.07	5552.08	4882.67	4977.38	4204.63	4366.94
Tangible Book Value	226,137	228,176	207,109	218,035	192,392	199,816
Tangible Book Value Per Share	5417.97	5504.58	4838.42	4932.32	4171.95	4332.92
Order Backlog	-	1,899	3,403	2,613	2,098	1,479

Data Source: S&P Global Market Intelligence Last updated: Nov 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error